We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Cardinal Health Inc (CAH) is a leading medical distribution business with stocks listed in the US. It opened the day at US$52.86 after a previous close of US$53.69. During the day the price has varied from a low of USD51.96 to a high of USD52.945. The latest price was USD52.27 (25 minute delay). Cardinal Health is listed on the NYSE. All prices are listed in US Dollars.
Our top pick for
US stocks
Our top pick for
Overall broker
Our top pick for
Low-cost broker
| Open | US$52.86 |
|---|---|
| High | US$52.945 |
| Low | US$51.96 |
| Close | US$52.27 |
| Previous close | US$53.69 |
| Change | US$-1.42 |
| Change % | -2.6448% |
| Volume | 1,978,934 |
| 52-week range | US$45.0319 - US$64.53 |
|---|---|
| 50-day moving average | US$56.8686 |
| 200-day moving average | US$52.9846 |
| Target price | US$60.54 |
| PE ratio | N/A |
| Dividend yield | US$1.963 (3.85%) |
| Earnings per share (TTM) | US$-3.377 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Use the fields above to explore the returns from a historical investment. Please refer to the charts further up this page to see performance over 5 years, or other periods. Past performance doesn't indicate future results. Capital is at risk.
Historical closes compared with the last close of $52.27
| 1 week (2022-06-24) | -4.00% |
|---|---|
| 1 month (2022-05-31) | -7.19% |
| 3 months (2022-03-28) | -9.57% |
| 6 months (2021-12-31) | 1.51% |
| 1 year (2021-07-01) | -9.79% |
|---|---|
| 2 years (2020-07-01) | 1.14% |
| 3 years (2019-07-01) | 9.90% |
| 5 years (2017-06-30) | -32.92% |
Valuing Cardinal Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cardinal Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Cardinal Health's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.4938. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Cardinal Health's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Cardinal Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$2.4 billion (£2 billion).
The EBITDA is a measure of a Cardinal Health's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | US$176.8 billion |
|---|---|
| Operating margin TTM | 0.98% |
| Gross profit TTM | US$7 billion |
| Return on assets TTM | 2.53% |
| Return on equity TTM | -173.3% |
| Profit margin | -0.54% |
| Book value | 3.603 |
| Market capitalisation | US$14.4 billion |
TTM: trailing 12 months
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Cardinal Health.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 12.66
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Cardinal Health's overall score of 12.66 (as at 01/01/2019) is excellent – landing it in it in the 6th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Cardinal Health is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 0.25/100
Social score: 5.84/100
Governance score: 1.08/100
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Cardinal Health scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Cardinal Health hasn't always managed to keep its nose clean.
Cardinal Health Inc was last rated for ESG on: 2019-01-01.
| Total ESG score | 12.66 |
|---|---|
| Total ESG percentile | 6.34 |
| Environmental score | 0.25 |
| Social score | 5.84 |
| Governance score | 1.08 |
| Level of controversy | 3 |
Dividend payout ratio: 41.17% of net profits
Recently Cardinal Health has paid out, on average, around 41.17% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.85% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Cardinal Health shareholders could enjoy a 3.85% return on their shares, in the form of dividend payments. In Cardinal Health's case, that would currently equate to about $1.963 per share.
While Cardinal Health's payout ratio might seem fairly standard, it's worth remembering that Cardinal Health may be investing much of the rest of its net profits in future growth.
Cardinal Health's most recent dividend payout was on 15 July 2022. The latest dividend was paid out to all shareholders who bought their shares by 30 June 2022 (the "ex-dividend date").
Cardinal Health's shares were split on a 3:2 basis on 23 April 2001. So if you had owned 2 shares the day before the split, the next day you would own 3 shares. This wouldn't directly have changed the overall worth of your Cardinal Health shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Cardinal Health shares which in turn could have impacted Cardinal Health's share price.
Over the last 12 months, Cardinal Health's shares have ranged in value from as little as US$45.0319 up to US$64.53. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Cardinal Health's is 0.8339. This would suggest that Cardinal Health's shares are less volatile than average (for this exchange).
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. It has a collaboration agreement with Journey Biosciences, Inc. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.
Everything we know about the Australia Sunny Glass Group IPO, plus information on how to buy in.
Steps to owning and managing Kincora Copper shares.
Everything we know about the Dragon Mountain Gold IPO, plus information on how to buy in.
Steps to owning and managing Arcadia Minerals shares.
Steps to owning and managing Nexgen Energy shares.
Steps to owning and managing Keypath Education shares.
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
Steps to owning and managing EBR Systems shares.
Steps to owning and managing 5E Advanced Materials shares.
